Total Payments
$199,883
2024 Payments
$34,894
Companies
16
Transactions
261
Medicare Patients
67
Medicare Billing
$7,181
Payment Breakdown by Category
Other$108,911 (54.5%)
Consulting$63,116 (31.6%)
Travel$21,868 (10.9%)
Food & Beverage$5,988 (3.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $108,911 | 55 | 54.5% |
| Consulting Fee | $63,116 | 30 | 31.6% |
| Travel and Lodging | $21,868 | 88 | 10.9% |
| Food and Beverage | $5,988 | 88 | 3.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $103,942 | 123 | $0 (2024) |
| SANOFI PASTEUR INC. | $57,423 | 65 | $0 (2023) |
| PFIZER INC. | $16,428 | 18 | $0 (2024) |
| Valneva Usa, Inc. | $13,655 | 20 | $0 (2024) |
| Gilead Sciences, Inc. | $7,132 | 18 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $337.22 | 3 | $0 (2019) |
| Allergan Inc. | $234.62 | 3 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $209.22 | 2 | $0 (2020) |
| ViiV Healthcare Company | $124.98 | 1 | $0 (2021) |
| Insmed, Inc. | $119.05 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $34,894 | 41 | Merck Sharp & Dohme LLC ($25,154) |
| 2023 | $29,855 | 36 | PFIZER INC. ($13,024) |
| 2022 | $21,675 | 32 | SANOFI PASTEUR INC. ($7,751) |
| 2021 | $20,486 | 12 | SANOFI PASTEUR INC. ($10,932) |
| 2020 | $27,702 | 27 | Merck Sharp & Dohme Corporation ($19,205) |
| 2019 | $24,986 | 44 | SANOFI PASTEUR INC. ($12,714) |
| 2018 | $24,322 | 34 | Merck Sharp & Dohme Corporation ($15,827) |
| 2017 | $15,965 | 35 | Merck Sharp & Dohme Corporation ($11,944) |
All Payment Transactions
261 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| Category: VACCINE | ||||||
| 12/11/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,590.00 | General |
| Category: VACCINE | ||||||
| 12/11/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: VACCINE | ||||||
| 12/11/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Travel and Lodging | Cash or cash equivalent | $30.90 | General |
| Category: VACCINE | ||||||
| 12/04/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,590.00 | General |
| Category: VACCINE | ||||||
| 12/04/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,590.00 | General |
| Category: VACCINE | ||||||
| 12/04/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: VACCINE | ||||||
| 12/04/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| Category: VACCINE | ||||||
| 12/03/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Travel and Lodging | In-kind items and services | $908.54 | General |
| Category: VACCINE | ||||||
| 12/03/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Travel and Lodging | In-kind items and services | $808.89 | General |
| Category: VACCINE | ||||||
| 12/03/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Travel and Lodging | In-kind items and services | $191.32 | General |
| Category: VACCINE | ||||||
| 12/03/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $102.88 | General |
| Category: VACCINE | ||||||
| 11/14/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $94.08 | General |
| Category: VACCINE | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Travel and Lodging | In-kind items and services | $198.63 | General |
| Category: VACCINE | ||||||
| 11/07/2024 | Merck Sharp & Dohme LLC | CAPVAXIVE (Biological) | Food and Beverage | In-kind items and services | $126.08 | General |
| Category: VACCINE | ||||||
| 11/05/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $6.93 | General |
| 07/03/2024 | PFIZER INC. | PENBRAYA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $550.00 | General |
| Category: VACCINES | ||||||
| 05/08/2024 | Merck Sharp & Dohme LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| 05/08/2024 | PFIZER INC. | PENBRAYA (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,650.00 | General |
| Category: VACCINES | ||||||
| 05/03/2024 | Merck Sharp & Dohme LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,850.00 | General |
| 04/24/2024 | Merck Sharp & Dohme LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,590.00 | General |
| 04/12/2024 | Merck Sharp & Dohme LLC | — | Travel and Lodging | Cash or cash equivalent | $150.00 | General |
| 04/11/2024 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $319.41 | General |
| 04/11/2024 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $314.60 | General |
| 04/11/2024 | Merck Sharp & Dohme LLC | — | Travel and Lodging | In-kind items and services | $239.96 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 11 | 15 | $4,095 | $948.53 |
| 2021 | 2 | 30 | 56 | $18,448 | $4,089 |
| 2020 | 2 | 26 | 40 | $11,182 | $2,143 |
Total Patients
67
Total Services
111
Medicare Billing
$7,181
Procedure Codes
5
All Medicare Procedures & Services
5 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 11 | 15 | $4,095 | $948.53 | 23.2% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 28 | $10,796 | $2,413 | 22.4% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 18 | 28 | $7,652 | $1,676 | 21.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 12 | 21 | $6,888 | $1,519 | 22.1% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 14 | 19 | $4,294 | $624.61 | 14.5% |
About Dr. Vincent Hsu, MD
Dr. Vincent Hsu, MD is a Infectious Disease healthcare provider based in Orlando, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/21/2005. The National Provider Identifier (NPI) number assigned to this provider is 1255331146.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Vincent Hsu, MD has received a total of $199,883 in payments from pharmaceutical and medical device companies, with $34,894 received in 2024. These payments were reported across 261 transactions from 16 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($108,911).
As a Medicare-enrolled provider, Hsu has provided services to 67 Medicare beneficiaries, totaling 111 services with total Medicare billing of $7,181. Data is available for 3 years (2020–2022), covering 5 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Location Orlando, FL
- Active Since 07/21/2005
- Last Updated 11/11/2008
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1255331146
Products in Payments
- PNEUMOVAX 23 (Biological) $37,686
- FLUZONE HIGH-DOSE (Drug) $19,639
- FLUZONE HIGH-DOSE (Biological) $12,586
- CAPVAXIVE (Biological) $12,531
- FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE (Biological) $11,664
- VAXNEUVANCE (Biological) $10,971
- PENBRAYA (Biological) $9,872
- MENQUADFI (Biological) $5,524
- DISEASE STATE (Drug) $2,950
- ZOSTAVAX (Biological) $2,406
- ABRYSVO (Biological) $2,000
- IXCHIQ (Drug) $2,000
- FLUZONE QUADRIVALENT (Biological) $1,278
- Veklury (Drug) $1,260
- PREVNAR - 13 (Biological) $1,000
- FLUBLOK QUADRIVALENT (Drug) $942.00
- FLUZONE QUADRIVALENT NORTHERN HEMISPHERE (Biological) $499.00
- ZERBAXA (Drug) $257.14
- OFEV (Drug) $231.50
- NO PRODUCT DISCUSSED (Drug) $177.76
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Orlando
Dr. Charlotte-Paige Rolle, M.d, M.D
Infectious Disease — Payments: $520,539
Infectious Disease $520,539
Federico Hinestrosa, Md, MD
Infectious Disease — Payments: $331,463
Infectious Disease $331,463
Edwin Dejesus, Md, MD
Infectious Disease — Payments: $132,951
Infectious Disease $132,951
Patricia Couto, M.d, M.D
Infectious Disease — Payments: $22,106
Infectious Disease $22,106
Dr. William Robbins, M.d, M.D
Infectious Disease — Payments: $19,785
Infectious Disease $19,785
Dr. Jose Giron, M.d, M.D
Infectious Disease — Payments: $16,474
Infectious Disease $16,474